Cellular constituents in the BALF
. | . | . | . | . | . | Median cell differentials . | . | . | . | . | . | . | . | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | . | . | . | Median BAL cell density, ×104/mL . | Macrophage . | . | Lymphocyte . | . | Neutrophil . | . | Eosinophil . | . | |||||||
. | No. subjects . | Sex, F/M . | Median age, y . | Median BAL recovery, % . | . | No., ×104/mL . | % . | No., ×104/mL . | % . | No., ×104/mL . | % . | No., ×104/mL . | % . | |||||||
Patients with iPAP | 34 | 10/24 | 52 (28-79) | 70.2 (48.7-73.3) | 10.5 (2.8-55.9) | 4.2 (2.17-26.5)* | 60.0 (5.9-90.9)* | 3.2 (0.5-52.6)* | 32.5 (6.8-94.1)* | 0.3 (0.0-4.8) | 2.3 (0.0-15.0)* | 0.0 (0.0-0.3) | 0.3 (0.0-6.3) | |||||||
Control | 18 | 10/8 | 50 (27-72) | 67.0 (59.3-77.0) | 14.0 (3.8-42.2) | 13.2 (3.3-39.8) | 93.3 (84.0-96.8) | 0.8 (0.2-3.1) | 6.0 (2.9-14.0) | 0.1 (0.0-0.4) | 0.3 (0.0-2.0) | 0.0 (0.0-0.2) | 0.0 (0.0-1.0) |
. | . | . | . | . | . | Median cell differentials . | . | . | . | . | . | . | . | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | . | . | . | Median BAL cell density, ×104/mL . | Macrophage . | . | Lymphocyte . | . | Neutrophil . | . | Eosinophil . | . | |||||||
. | No. subjects . | Sex, F/M . | Median age, y . | Median BAL recovery, % . | . | No., ×104/mL . | % . | No., ×104/mL . | % . | No., ×104/mL . | % . | No., ×104/mL . | % . | |||||||
Patients with iPAP | 34 | 10/24 | 52 (28-79) | 70.2 (48.7-73.3) | 10.5 (2.8-55.9) | 4.2 (2.17-26.5)* | 60.0 (5.9-90.9)* | 3.2 (0.5-52.6)* | 32.5 (6.8-94.1)* | 0.3 (0.0-4.8) | 2.3 (0.0-15.0)* | 0.0 (0.0-0.3) | 0.3 (0.0-6.3) | |||||||
Control | 18 | 10/8 | 50 (27-72) | 67.0 (59.3-77.0) | 14.0 (3.8-42.2) | 13.2 (3.3-39.8) | 93.3 (84.0-96.8) | 0.8 (0.2-3.1) | 6.0 (2.9-14.0) | 0.1 (0.0-0.4) | 0.3 (0.0-2.0) | 0.0 (0.0-0.2) | 0.0 (0.0-1.0) |
Numbers in parentheses are ranges.
P < .05 compared with control.